1Wiese S, Reidegeld KA, Meyer HE, et al. Protein labeling by iTRAQ: a new tool for quantitative mass spectrometry in proteome research[J]. Proteomics, 2007, 7 ( 3 ) : 340- 350.
2Zieske LR. A perspective on the use of iTRAQ reagent technology for protein complex and profiling studies[J]. J Exp Bot,2006,57(7) :1501-1508.
4Pawar H, Kashyap MK, Sahasrabuddhe NA, et al. Quantitative tissue proteomics of esophageal squamous cell carcinoma for novel biomarker discovery[J]. Cancer Biol Ther,2011,12(6) :510-522.
5Loei H,Tan HT, Lira TK, et al. Mining the gastric cancer secretome:identification of GRN as a potential diagnostic marker for early gastric cancer[J]. J Proteome Res, 2011, 11(3) : 1759-1772.
6Chong PK, Lee H, Loh MC,et al. Upregulation of plasma C9 protein in gastric cancer patients [J ]. Proteomics, 2010,10(18) : 3210-3221.
7Chong PK,Lee H,Zhou J,et al. ITIH3 is a potential biomarker for early detection of gastric cancer[J]. J Proteome Res,2010,9(7) : 3671-3679.
8Chaerkady R, Harsha HC, Nalli A, et al. A quantitative proteomic approach for ideatifieation of potential biomarkers in hepatocellular carcinoma [J]. J Proteome Res, 2008,7(10) :4289-4298.
9Lee H J, Na K, Choi EY, et al. Simple method for quantitative analysis of N-linked glycoproteins in hepatocellular carcinoma specimens[J]. J Proteome Res, 2010,9 (1) : 308- 318.
10Wang C, Guo K, Gao D, et al. Identification of transaldolase as a novel serum biomarker for hepatocellular carcinoma metastasis using xenografted mouse model and clinic samples[J]. Cancer Lett,2011,313(2) : 154-166.
